Research & clinical tools, built for clinicians

A clinician's
research + clinical toolkit

A full clinical-research workflow lab, 483+ bedside calculators and scores, and specialty-deep references. Free, mobile-friendly, computed locally — your data is never uploaded.

Browse clinical tools →Research Labs
🌐 中文站 →
483clinical tools348care pathways233guideline decisions56research tools
● ResFlow · end-to-end clinical research
From question to paper — one statistical thread →
Logistic / Cox / linear modelling · internal bootstrap correction · external validation · nomograms / survival curves / calibration · one-click report with figures + R cross-check. Free, mobile-friendly, data stays on your device.

Clinical tools

All 483 tools →
🩸
Lactate clearance
Calculates the percent clearance between two lactate values to assess the resuscitation response.
📐
Measurement reference
Enter gestational age and a measured value (mm) to obtain the GA reference mean ± SD / normal range, z-score and percentile, with possible problems and clinical management direction. Covers BPD/HC/AC/FL/transcerebellar diameter/lateral ventricle/cisterna magna/nuchal fold/NT.
🫀
Fick CO
Estimates cardiac output (CO) by the Fick principle from oxygen consumption and arteriovenous oxygen difference, also giving the cardiac index (CI) when BSA is provided.
🩸
Warfarin INR
Target INR, high-INR/bleeding management (ACCP/CHEST), interactions and missed-dose points.
🩸
HAS-BLED
Major-bleeding risk on anticoagulation in atrial fibrillation.
🦋
Hypothyroid LT4 start
Based on hypothyroidism type, TSH, and cardiac/pregnancy status, decide whether to start levothyroxine and the starting strategy and estimated dose.
🧬
PNI
Nutrition/immune index predicting surgical and oncologic outcomes.
💪
SARC-F
Five-item rapid screen for sarcopenia risk, suitable for community and outpatient use.
🦠
Duke Endocarditis
Determines infective endocarditis as definite/possible/rejected by major/minor criteria (Modified Duke / 2023 Duke-ISCVID clinical criteria).
🫀
CAD-RADS
Grade by the most severe luminal stenosis (0–5/N) and the ischaemia and high-risk-plaque modifiers, giving the CAD-RADS 2.0 management direction.
🩻
O-RADS
Give the malignancy risk and management (follow-up / MRI / gyn-oncology) for an ACR O-RADS US category.
🦋
TI-RADS
Score five ultrasound features per ACR TI-RADS (TR1–5) and, with the maximum nodule diameter, return an FNA or follow-up recommendation.
Guideline decisions

Turn guidelines into decisions

Enter the patient → risk stratification → thresholds → guideline recommendation, each with class of recommendation, level of evidence and source guideline. Computed locally; decision support for licensed clinicians.

Care pathways

Turn guidelines into pathways

From first contact to disposition, step through the decision tree: red / amber / green stratification → thresholds → guideline recommendation. Each pathway is checked against current guidelines, computed locally — for licensed clinicians.

Emergency

Caustic (Strong Acid/Alkali) Ingestion — Management Pathway

The four nos (no emesis/lavage/neutralization/charcoal); airway first, early endoscopy grading at 12–24 h.

Decision tree · 3 nodesOpen →
Imaging

Fetal Encephalocele / Cranium Bifidum

Meningocele vs containing brain tissue; occipital most common; MRI assesses herniated contents + associated; check Meckel-Gruber.

Decision tree · 3 nodesOpen →
Neurology

Wernicke Encephalopathy — Management Pathway

Thiamine deficiency, the triad complete in only 16%; IV high-dose thiamine, before any glucose.

Decision tree · 3 nodesOpen →
Respiratory

Pleural Effusion (Light's Criteria) — Pathway

Thoracentesis for protein/LDH, Light's criteria classify exudate/transudate; suspected hemothorax/empyema → emergency drainage.

Decision tree · 3 nodesOpen →
Emergency

Drowning — Management Pathway

The core injury is hypoxia, ventilation first; the Heimlich maneuver is not recommended; symptomatic/hypoxic → oxygen ± intubation, observe asymptomatic for 4–8 h.

Decision tree · 3 nodesOpen →
Imaging

Fetal Anemia (MCA-PSV)

MCA-PSV ≥1.5 MoM (Mari) predicts moderate-severe anemia; check alloimmunization/parvovirus/thalassemia; ≥1.5 or hydrops → intrauterine transfusion.

Decision tree · 3 nodesOpen →
Infectious disease

Malaria — Management Pathway

Confirm with blood film/RDT; triage by WHO severe criteria — IV artesunate for severe, oral ACT for uncomplicated.

Decision tree · 3 nodesOpen →
Surgical approach decision

Cervical Cancer · By FIGO Stage + Approach

IA1 conization/hysterectomy; IA2 modified radical + nodes; IB1-2/IIA1 radical hysterectomy (open superior to minimally invasive LACC); early small-volume fertility-sparing trachelectomy; locally advanced concurrent chemoradiation.

Decision tree · 6 nodesOpen →
Browse all 348 care pathways →
Research Labs

Statistics, ready to run

Fill in your data, get the result: agreement, diagnostic accuracy, survival, meta-analysis, modelling and more. Every tool computes locally in your browser — nothing is uploaded or stored.

Ready

Decision Curve Analysis (DCA)

Assess the clinical usefulness of a prediction model: net benefit across threshold probabilities, compared with the treat-all and treat-none reference lines, comparing several models at once, with an exportable curve. A standard for prediction-model papers.

Ready to runOpen →
Ready

Lin's CCC (Concordance Correlation)

Agreement between two measurement methods: CCC combines precision (Pearson r) and accuracy (bias-correction factor Cb), catching systematic bias that r alone misses — complementary to Bland–Altman. Gives CCC, r, Cb with 95% CI.

Ready to runOpen →
Ready

Win Ratio

Stratified composite-endpoint win ratio (Pocock 2012): compare time-to-event endpoints by priority, then a secondary continuous measure; pairwise treatment×control comparisons count wins/losses/ties, giving Win Ratio, Win Odds, Net Benefit and bootstrap 95% CI. Common in heart-failure/cardiovascular trials.

Frontier methodOpen →
Ready

RR / OR / NNT Calculator

Enter a 2×2 table to compute relative risk RR, odds ratio OR, absolute risk difference ARD, relative risk reduction RRR and number needed to treat NNT, with 95% CIs for ratios and the risk difference. Common for interpreting cohort/case-control/RCT outcomes.

Ready to runOpen →
Ready

ROC Curve & Diagnostic Performance

Enter a gold standard and measured values to compute AUC (with 95% CI), draw the ROC curve, and give the optimal cutoff by Youden index with its sensitivity/specificity. A core tool for diagnostic imaging research.

Ready to runOpen →
Ready

Binary Logistic Regression

Analyze multiple factors' effects on a binary outcome, outputting each factor's OR, 95% CI, significance and model fit indices. A core method for clinical risk-factor analysis and prediction models.

Ready to runOpen →
Ready

Kappa Agreement

Inter-rater classification agreement: Cohen's Kappa (nominal) plus linear/quadratic weighted Kappa for ordinal grades, with a confusion matrix and agreement interpretation. Common for imaging-grade agreement.

Ready to runOpen →
Ready

NRI / IDI Reclassification

Incremental value of a new vs old prediction model: net reclassification improvement (NRI, continuous and categorical) and integrated discrimination improvement (IDI). When adding a new marker barely raises AUC, these quantify the reclassification and discrimination gain.

Ready to runOpen →
Browse all 56 research tools →